Gastric Hypersecretory Conditions
📧 Sign up to get email alerts when something new happens for Gastric Hypersecretory Conditions.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-03-04FDA Approved: OMEPRAZOLE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for Camber Pharmaceuticals' Omeprazole, a generic proton pump inhibitor, under the ANDA process.